ciprofloxacin has been researched along with chitosan in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (6.67) | 29.6817 |
2010's | 43 (47.78) | 24.3611 |
2020's | 41 (45.56) | 2.80 |
Authors | Studies |
---|---|
Gu, Q; Hou, C; Jiang, L; Yin, C | 1 |
Alper, M; Araman, A; Cevher, E; Gürcan, D; Mülazimoglu, L; Orhan, Z; Ozsoy, Y | 1 |
Banerjee, R; Jain, D | 1 |
Bonferoni, MC; Caramella, C; Ferrari, F; Gibin, S; Rossi, S; Sandri, G | 1 |
Pandit, JK; Srinatha, A | 1 |
Li, Y; Morsi, YS; Shen, J; Shi, P; Zhang, L; Zou, Q; Zuo, Y | 1 |
Elmaradny, HA; Mehanna, MM; Samaha, MW | 1 |
Abdelbary, G | 1 |
Garg, D; Gupta, GK; Jain, V; Keshava, GB; Mishra, PR; Shukla, PK; Shukla, R; Singodia, D | 1 |
Mishra, PR | 1 |
Bansal, AK; Ghosh, A; Pandit, JK; Verma, A | 1 |
Deng, Y; Luo, J; Lv, W; Sun, Y | 1 |
Barbetta, A; del Monte, F; Dentini, M; Ferrer, ML; Gutiérrez, MC; Nardecchia, S; Serrano, MC | 1 |
Hou, W; Jia, Y; Su, C; Zhao, L; Zhu, B | 1 |
Alpar, O; Awad, G; El-Shamy, AE; Kan, PL; Mortada, N; Osman, R | 1 |
Hadinoto, K; Yang, Y | 1 |
Ben Thomas, M; Chakravortty, D; Elango, M; Gnanadhas, DP; Raichur, AM | 1 |
Jain, V; Mishra, PR; Pal, R; Shukla, P | 1 |
Ceci, E; Cometa, S; De Giglio, E; Falconi, M; Ferretti, C; Iatta, R; Mattioli-Belmonte, M; Trapani, A | 1 |
Han, W; Hornyák, I; Horváthy, DB; Kalugyer, P; Lacza, Z; Madácsi, E; Szendrői, M; Vácz, G | 1 |
Du, J; El-Sherbiny, IM; Smyth, HD | 1 |
Kariminia, S; Shamsipur, A; Shamsipur, M | 1 |
El-Sayed, MMH; Gamal-Eldeen, AM; Mahmoud, AA; Mostafa, AA | 1 |
Chen, GG; Guan, Y; Peng, F; Qi, XM; Sun, RC | 1 |
Blango, MG; Erman, A; Hergouth, VK; Kos, MK; Mulvey, MA; Veranic, P | 1 |
Kyzioł, A; Mazgała, A; Michna, J; Regiel-Futyra, A; Sebastian, V | 1 |
Akbari, A; Wu, J | 1 |
Hasan, S; Prestidge, CA; Thierry, B; Thomas, N | 1 |
Aldana, AA; Alovero, F; García, MC; Jimenez-Kairuz, AF; Manzo, RH; Martinelli, M; Strumia, MC; Tártara, LI | 1 |
Baranwal, G; Biswas, R; R, J; S, E; S, S; T R, N; V K, R | 1 |
Behrens, P; de Cassan, D; Glasmacher, B; Hänsch, R; Hoffmann, A; Hoheisel, AL; Menzel, H; Roger, Y; Schmidt, N; Sydow, S | 1 |
Farhangi, M; Kobarfard, F; Mahboubi, A; Mortazavi, SA; Vatanara, A | 1 |
Barresi, AA; Fissore, D; Granero, GE; Onnainty, R; Zelenková, T | 1 |
Beenken, KE; Courtney, HS; Haggard, WO; Jennings, JA; Smeltzer, MS; Wells, CM | 1 |
Afzal, MZ; Javed, A; Liu, J; Song, C; Sun, XF; Wang, SG | 1 |
Gao, G; Jia, HR; Jiang, YW; Wu, FG | 1 |
Hanna, DH; Saad, GR | 1 |
El Sherif, Y; El-Samie, EA; Elwahy, AHM; Marei, N; Salah, TA | 1 |
Karimi, MH; Mahdavinia, GR; Massoumi, B; Soltaniniya, M | 1 |
Baklykov, A; Bratskaya, S; Marinin, D; Modin, E; Pestov, A; Privar, Y; Shashura, D | 1 |
Agrawal, AK; Anjum, MM; Gade, S; Pandey, N; Patel, KK; Singh, S; Tilak, R; Tripathi, M | 1 |
Hosseini, M; Mohseni-Bandpei, A; Rasoulzadeh, H; Safari, M | 1 |
Alemdar, N; Aycan, D; Evranos, B | 1 |
Pawar, V; Srivastava, R | 1 |
Karadenizli, A; Kenar, H; Kucukoglu, V; Uzuner, H | 1 |
El-Kasapy, A; El-Sherbiny, IM; Khalil, IA; Mostafa, A; Osman, A; Salah, M; Shokry, MM | 1 |
Yang, S; Zhang, D; Zhang, X | 1 |
Abioye, A; Adepoju-Bello, AA; Coker, HAB; Dudzinska, P; Sanyaolu, A | 1 |
Casula, L; Fadda, AM; Kocbek, P; Kristl, J; Lapanje, A; Luštrik, M; Rijavec, T; Zupančič, Š | 1 |
Uskoković, V | 1 |
Alvarez, VA; Barud, HS; Cacicedo, ML; Castro, GR; Islan, GA; Pacheco, G | 1 |
Abd Elsalam, EA; Abdelaziz, MM; El-Sherbiny, IM; Khalil, IA; Shabaiek, HF | 1 |
Afifi, NN; Arafa, MG; Mousa, HA | 1 |
Adimi, T; Bayat, F; Karimi, AR | 1 |
Cheng, B; Fang, Q; Feng, L; Guo, R; Liu, T; Wang, X; Wei, S; Xu, P; Yao, Z | 1 |
Kamel, R; Salah, NM; Salama, A; Shaffie, NM | 1 |
Afzal, M; Alenezi, SK; Alhakamy, NA; Alharbi, KS; Alotaibi, NH; Alruwaili, NK; Alshehri, S; Bukhari, SNA; Imam, SS | 1 |
El-Alfy, EA; El-Bisi, MK; Ibrahim, HM; Taha, GM | 1 |
Blanchemain, N; Cazaux, F; Chai, F; Foligné, B; Gauzit Amiel, A; Lopez, M; Martel, B; Maton, M; Neut, C; Palomino-Durand, C | 1 |
Chen, H; Hu, H; Huang, X; Huang, Z; Li, J; Liang, X; Su, D; Wang, S; Xu, Z; Yin, Y | 1 |
Araújo, ID; Faraco, AAG; Fernandes, SOA; Kobata, SI; Teixeira, LEM; Vidigal, PVT | 1 |
Becerra, Y; Palacio, DA; Rivas, BL; Urbano, BF | 1 |
Basta, AH; Lotfy, VF | 1 |
Divakar, S; Kumar, G; Mallick, SP; Singh, BN; Srivastava, P; Tripathi, S | 1 |
Farhangpazhouh, F; Hamidi, M; Hasan, M; Hashemikia, S; Hassanzadeh, A; Parsa, M | 1 |
Hosseini-Ashtiani, N; Tadjarodi, A; Zare-Dorabei, R | 1 |
Ait Said, H; Barroug, A; Ben Youcef, H; Hakkou, R; Lahcini, M; Lefeuvre, B; Noukrati, H; Oudadesse, H | 1 |
Aldosari, BN; Alfagih, IM; Aljunaidel, HA; Almarshidy, SS; Almurshedi, AS; Alquadeib, B; Eltahir, EKD; Mohamoud, AZ | 1 |
Acosta, N; Affes, S; Aranaz, I; Heras, Á; Maalej, H; Nasri, M | 1 |
Gosavi, S; Khare, T; Kumar, V; Mahalunkar, S; Shriram, V | 1 |
Arauzo, B; Lobera, MP; Monzon, A; Santamaria, J | 1 |
Huan, Y; Kong, Q; Li, C; Mou, H; Tang, Q; Wang, Y; Ying, R | 1 |
Chen, S; Cui, C; Li, X; Ma, J; Sun, S; Wu, S; Zhou, F | 1 |
Amiri, P; Kardan-Yamchi, J; Kazemian, H; Rezaei, F | 1 |
Asadi Karam, MR; Foroohi, F; Habibi, M; Haji Hossein Tabrizi, A; Mohammadian, T | 1 |
Alanazi, FK; Alenazi, ASM; Alsarra, IA; Alshehri, S; Bayomi, M; Haq, N; Shakeel, F; Soliman, NM | 1 |
Abbasi, SA; Ali, S; Andleeb, S; Awan, UA; Imdad, K; Mughal, TA; Nasreen, S; Raja, SA | 1 |
Abd El-Baky, RM; Aly, SA; Elsabahy, M; Hadiya, S; Ibrahem, RA | 1 |
Abbasi, A; Afzal, MZ; Hameed, S; Mohiuddin, M | 1 |
Cao, R; Hao, Y; He, S; Liu, Y; Song, K; Wang, L; Wen, J; Zhang, X; Zhang, Y; Zheng, W | 1 |
Egorov, AR; Golubev, R; Khubiev, O; Kirichuk, AA; Kritchenkov, AS; Kurliuk, AV; Lobanov, NN; Rubanik, VV; Tskhovrebov, AG | 1 |
Abu Elella, MH; Hassan, DA; Jalal, RR; Khutoryanskiy, VV; Ways, TMM | 1 |
Chen, J; Gu, Y; Li, P; Lyu, G; Wang, Z; Yang, G; Yang, S | 1 |
AbdElgawad, H; Ahmed, MA; Al-Askar, AA; Atia, KH; Hagras, FA; Hashem, AH; Kamel, MR; Ramadan, AA; Shehabeldine, AM | 1 |
Gorgin Karaji, Z; Kazemi, MH; Sajadimajd, S | 1 |
Ganeshbabu, M; Manoj, GM; Priya, JS; Puneeth, NPN; Selvan, RK; Shankar, H; Shobana, C | 1 |
Chen, S; Cui, C; Li, CM; Li, X; Ma, J; Sun, S; Wu, S; Zhou, F | 1 |
Kaur, M; Kaushik, A; Kumar, V; Paulik, C; Rattan, G; Sharma, K; Sharma, M; Singhal, S; Tewatia, P; Yoshitake, H | 1 |
Adamczyk, A; Draczyński, Z; Frączyk, J; Janczewski, Ł; Kaźmierski, S; Kolesińska, B; Kregiel, D; Neubauer, D; Potrzebowski, MJ; Rosiak, P; Sikorski, D | 1 |
Cui, Z; Li, Y; Shen, W; Shi, H; Wang, Y; Xu, C; Yang, Y; Yin, T | 1 |
90 other study(ies) available for ciprofloxacin and chitosan
Article | Year |
---|---|
[Research on carboxymethyl chitosan acting as the adjuvant for implantable degradable microspheres].
Topics: Absorbable Implants; Biocompatible Materials; Biodegradation, Environmental; Chitin; Chitosan; Ciprofloxacin; Cross-Linking Reagents; Delayed-Action Preparations; Drug Carriers; Humans; Microspheres | 2004 |
The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheres: their evaluation in an animal osteomyelitis model.
Topics: Animals; Anti-Infective Agents; Biocompatible Materials; Calorimetry, Differential Scanning; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Drug Evaluation, Preclinical; Male; Microscopy, Electron, Scanning; Microspheres; Osteomyelitis; Pectins; Rats; Rats, Wistar; Staphylococcal Infections; Treatment Outcome | 2006 |
Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery.
Topics: Albumins; Animals; Cattle; Chitosan; Ciprofloxacin; Drug Carriers; Drug Delivery Systems; Gelatin; Lipids; Nanoparticles; Nanotechnology; Particle Size; Polymers; Scattering, Radiation; Serum Albumin | 2008 |
Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties.
Topics: Acyclovir; Adjuvants, Pharmaceutic; Administration, Intravaginal; Animals; Biological Availability; Caco-2 Cells; Carboxypeptidases A; Cell Survival; Chitosan; Ciprofloxacin; Dextrans; Fluorescein-5-isothiocyanate; Humans; Intestinal Absorption; Leucyl Aminopeptidase; Mucous Membrane; Protease Inhibitors; Sus scrofa; Vaginal Creams, Foams, and Jellies; Viscosity | 2008 |
Multi-unit floating alginate system: effect of additives on ciprofloxacin release.
Topics: Alginates; Anti-Infective Agents; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Excipients; Hypromellose Derivatives; Methylcellulose; Particle Size; Polysaccharides, Bacterial; Solubility; Starch; Surface Properties | 2008 |
Improved properties of incorporated chitosan film with ethyl cellulose microspheres for controlled release.
Topics: Cell Survival; Cellulose; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Drug Stability; Microspheres; Solvents | 2009 |
Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
Topics: Adhesiveness; Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Delivery Systems; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Liposomes; Male; Microbial Sensitivity Tests; Molecular Weight; Permeability; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Rheology; Time Factors | 2010 |
Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
Topics: Adhesiveness; Animals; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Drug Carriers; Drug Compounding; Eye; Liposomes; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Mucous Membrane; Ophthalmic Solutions; Particle Size; Rabbits; Solubility; Staphylococcus aureus; Static Electricity; Surface Properties; Toxicity Tests, Acute | 2011 |
Ciprofloxacin surf-plexes in sub-micron emulsions: a novel approach to improve payload efficiency and antimicrobial efficacy.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Cell Line; Chitosan; Ciprofloxacin; Deoxycholic Acid; Emulsions; Escherichia coli; Excipients; Hydrophobic and Hydrophilic Interactions; Macrophages; Male; Mice; Mice, Inbred BALB C; Particle Size; Pseudomonas aeruginosa; Staphylococcus aureus; Surface-Active Agents; Viscosity | 2011 |
An investigation on the approach to target lipopolysaccharide through polymeric capped nano-structured formulation for the management of sepsis.
Topics: Animals; Anti-Infective Agents; Chitosan; Ciprofloxacin; Deoxycholic Acid; Drug Compounding; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Nanocapsules; Sepsis; Treatment Outcome | 2011 |
Low molecular mass chitosan as carrier for a hydrodynamically balanced system for sustained delivery of ciprofloxacin hydrochloride.
Topics: Calorimetry, Differential Scanning; Capsules; Cellulose; Chemical Phenomena; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Stability; Excipients; Feasibility Studies; Gastric Acid; Gelatin; Hydrodynamics; Hydrogen-Ion Concentration; Kinetics; Molecular Weight; Polysaccharides, Bacterial; Spectroscopy, Fourier Transform Infrared | 2012 |
Biomaterials immobilized with chitosan for rechargeable antimicrobial drug delivery.
Topics: Animals; Anti-Infective Agents; Bacteria; Biocompatible Materials; Biofilms; Cell Survival; Chitosan; Ciprofloxacin; Drug Delivery Systems; Fibroblasts; Membranes, Artificial; Microbial Sensitivity Tests; Ozone; Polyurethanes; Rats; Rats, Sprague-Dawley; Rifampin; Surface Properties; Time Factors | 2013 |
In situ precipitation of amorphous calcium phosphate and ciprofloxacin crystals during the formation of chitosan hydrogels and its application for drug delivery purposes.
Topics: Calcium Phosphates; Chitosan; Ciprofloxacin; Crystallization; Drug Delivery Systems; Hydrogels; Particle Size; Rheology; Surface Properties | 2012 |
Preparation of biocompatible carboxymethyl chitosan nanoparticles for delivery of antibiotic drug.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Cell Survival; Chitosan; Ciprofloxacin; Drug Delivery Systems; Escherichia coli; Humans; Nanoparticles | 2013 |
Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Cell Line; Chitosan; Ciprofloxacin; Dextrans; Drug Carriers; Drug Compounding; Drug Delivery Systems; Epithelial Cells; Excipients; Humans; Hydrogen-Ion Concentration; Lung; Microspheres; Polyethylene Glycols; Pseudomonas aeruginosa; Staphylococcus aureus | 2013 |
A highly sustainable and versatile granulation method of nanodrugs via their electrostatic adsorption onto chitosan microparticles as the granulation substrates.
Topics: Adsorption; Chemistry, Pharmaceutical; Chitosan; Ciprofloxacin; Curcumin; Nanoparticles; Static Electricity | 2013 |
Chitosan-dextran sulphate nanocapsule drug delivery system as an effective therapeutic against intraphagosomal pathogen Salmonella.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Chitosan; Ciprofloxacin; Dextran Sulfate; Disease Models, Animal; Drug Delivery Systems; Epithelial Cells; Macrophages; Mice; Mice, Inbred BALB C; Nanocapsules; Phagosomes; Salmonella; Salmonella Infections, Animal; Treatment Outcome | 2013 |
Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis.
Topics: Animals; Anti-Bacterial Agents; Cations; Chitosan; Ciprofloxacin; Deoxycholic Acid; Drug Carriers; Emulsions; Escherichia coli; Escherichia coli Infections; Lipopolysaccharides; Microbial Sensitivity Tests; Nanostructures; Particle Size; Peritonitis; Rats, Wistar; Sepsis; Technology, Pharmaceutical | 2014 |
Characterization and cytocompatibility of an antibiotic/chitosan/cyclodextrins nanocoating on titanium implants.
Topics: Anti-Bacterial Agents; beta-Cyclodextrins; Cell Line; Chitosan; Ciprofloxacin; Coated Materials, Biocompatible; gamma-Cyclodextrins; Humans; Nanoparticles; Prostheses and Implants; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Titanium | 2014 |
Increased release time of antibiotics from bone allografts through a novel biodegradable coating.
Topics: Allografts; Amoxicillin; Biocompatible Materials; Bone Transplantation; Chitosan; Ciprofloxacin; Humans; Infections; Polymers; Vancomycin | 2014 |
Swellable ciprofloxacin-loaded nano-in-micro hydrogel particles for local lung drug delivery.
Topics: Administration, Inhalation; Alginates; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cell Line; Chemistry, Pharmaceutical; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Hydrogels; Lung; Macrophages; Male; Mice; Nanomedicine; Nanoparticles; Particle Size; Polyethylene Glycols; Polymers; Rats, Sprague-Dawley; Solubility; Surface Properties; Technology, Pharmaceutical | 2014 |
Analytical characteristics and application of novel chitosan coated magnetic nanoparticles as an efficient drug delivery system for ciprofloxacin. Enhanced drug release kinetics by low-frequency ultrasounds.
Topics: Administration, Oral; Chitosan; Ciprofloxacin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Kinetics; Magnetite Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2016 |
Bioactive/Natural Polymeric Scaffolds Loaded with Ciprofloxacin for Treatment of Osteomyelitis.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Cell Proliferation; Ceramics; Chitosan; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Humans; Osteomyelitis; Porosity; Tissue Engineering; Tissue Scaffolds | 2017 |
Facile approach to prepare drug-loading film from hemicelluloses and chitosan.
Topics: Anti-Bacterial Agents; Bandages; Chitosan; Ciprofloxacin; Cross-Linking Reagents; Drug Delivery Systems; Drug Liberation; Epichlorohydrin; Polysaccharides; Tensile Strength | 2016 |
Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.
Topics: Animals; Anti-Bacterial Agents; Bacteriuria; Chitosan; Ciprofloxacin; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred C57BL; Recurrence; Urinary Bladder; Uropathogenic Escherichia coli; Urothelium | 2017 |
Preparation and characterization of alginate/chitosan formulations for ciprofloxacin-controlled delivery.
Topics: Alginates; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Kinetics; Particle Size | 2017 |
Ovomucin nanoparticles: promising carriers for mucosal delivery of drugs and bioactive compounds.
Topics: Acrylic Resins; Alginates; Chitosan; Ciprofloxacin; Drug Carriers; Drug Liberation; Gastric Juice; Glucuronic Acid; Hexuronic Acids; Intestinal Mucosa; Intestinal Secretions; Kinetics; Nanoparticles; Ovomucin; Particle Size; Rheology; Tensile Strength | 2017 |
Controlled and Localized Nitric Oxide Precursor Delivery From Chitosan Gels to Staphylococcus aureus Biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Chitosan; Ciprofloxacin; Drug Liberation; Gels; Humans; Isosorbide Dinitrate; Nitric Oxide; Polymers; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Bioadhesive and biocompatible films as wound dressing materials based on a novel dendronized chitosan loaded with ciprofloxacin.
Topics: Animals; Bandages; Biocompatible Materials; Chitosan; Ciprofloxacin; Drug Delivery Systems; Rabbits | 2017 |
Fucoidan coated ciprofloxacin loaded chitosan nanoparticles for the treatment of intracellular and biofilm infections of Salmonella.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chitosan; Ciprofloxacin; Drosophila melanogaster; Drug Delivery Systems; Female; Humans; Male; Mice; Microscopy, Electron; Nanoparticles; Polysaccharides; RAW 264.7 Cells; Salmonella; Salmonella Infections; Spectroscopy, Fourier Transform Infrared | 2017 |
Attachment of nanoparticulate drug-release systems on poly(ε-caprolactone) nanofibers via a graftpolymer as interlayer.
Topics: Cell Death; Chitosan; Ciprofloxacin; Crystallization; Drug Delivery Systems; Drug Liberation; Humans; Nanofibers; Nanoparticles; Polyesters; Proton Magnetic Resonance Spectroscopy; Water; Wettability | 2018 |
Preparation of an optimized ciprofloxacin-loaded chitosan nanomicelle with enhanced antibacterial activity.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Drug Carriers; Drug Compounding; Fatty Acids; Klebsiella pneumoniae; Micelles; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Streptococcus pneumoniae | 2018 |
Use of microreactors and freeze-drying in the manufacturing process of chitosan coated PCL nanoparticles.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Drug Carriers; Drug Compounding; Drug Stability; Freeze Drying; Nanoparticles; Poloxamer; Polyesters; Sucrose | 2018 |
Ciprofloxacin and Rifampin Dual Antibiotic-Loaded Biopolymer Chitosan Sponge for Bacterial Inhibition.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Bacterial Infections; Biopolymers; Chitosan; Chromatography, High Pressure Liquid; Ciprofloxacin; Mice; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus | 2018 |
Enhancement of ciprofloxacin sorption on chitosan/biochar hydrogel beads.
Topics: Adsorption; Charcoal; Chitosan; Ciprofloxacin; Hydrogels; Hydrogen-Ion Concentration; Kinetics; Solutions; Water Pollutants, Chemical | 2018 |
Near-infrared light-controllable on-demand antibiotics release using thermo-sensitive hydrogel-based drug reservoir for combating bacterial infection.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Female; Hydrogels; Indoles; Infrared Rays; Mice, Inbred BALB C; Nanoparticles; Polymers; Staphylococcal Skin Infections; Staphylococcus aureus; Temperature | 2019 |
Encapsulation of ciprofloxacin within modified xanthan gum- chitosan based hydrogel for drug delivery.
Topics: Anti-Bacterial Agents; Cell Line; Cell Survival; Chitosan; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Polysaccharides, Bacterial; Structure-Activity Relationship | 2019 |
Enhanced antibacterial activity of Egyptian local insects' chitosan-based nanoparticles loaded with ciprofloxacin-HCl.
Topics: Acetylation; Animals; Anti-Bacterial Agents; Bacteria; Chitosan; Ciprofloxacin; Diffusion; Drug Liberation; Insecta; Kinetics; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared; Static Electricity; Time Factors; X-Ray Diffraction | 2019 |
In vitro evaluation of sustained ciprofloxacin release from κ-carrageenan-crosslinked chitosan/hydroxyapatite hydrogel nanocomposites.
Topics: Anti-Bacterial Agents; Carrageenan; Chitosan; Ciprofloxacin; Cross-Linking Reagents; Drug Liberation; Durapatite; Escherichia coli; Hydrogels; Kinetics; Microbial Sensitivity Tests; Nanocomposites; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; X-Ray Diffraction | 2019 |
Metal-chelate sorbents based on carboxyalkylchitosans: Ciprofloxacin uptake by Cu(II) and Al(III)-chelated cryogels of N-(2-carboxyethyl)chitosan.
Topics: Adsorption; Aluminum; Chelating Agents; Chitosan; Ciprofloxacin; Copper; Cryogels; Fluoroquinolones; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Molecular Structure; Water Pollutants, Chemical | 2019 |
Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chitosan; Ciprofloxacin; Cystic Fibrosis; Drug Liberation; Enzymes, Immobilized; Erythrocytes; Hemolysis; Humans; Lung; Male; Nanoparticles; Platelet Aggregation; Polysaccharide-Lyases; Pseudomonas aeruginosa; Pseudomonas Infections; Rats, Wistar | 2019 |
Mechanistic investigation of ciprofloxacin recovery by magnetite-imprinted chitosan nanocomposite: Isotherm, kinetic, thermodynamic and reusability studies.
Topics: Adsorption; Chitosan; Ciprofloxacin; Ferrosoferric Oxide; Kinetics; Models, Chemical; Nanocomposites; Thermodynamics | 2019 |
Production of ciprofloxacin loaded chitosan/gelatin/bone ash wound dressing with improved mechanical properties.
Topics: Animals; Anti-Bacterial Agents; Bacillus subtilis; Bandages; Cell Line; Chitosan; Ciprofloxacin; Drug Liberation; Elastic Modulus; Escherichia coli; Gelatin; Mice; Microbial Sensitivity Tests; Minerals; Oxygen; Permeability; Tensile Strength | 2019 |
Chitosan-polycaprolactone blend sponges for management of chronic osteomyelitis: A preliminary characterization and in vitro evaluation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Cell Line; Cell Survival; Chitosan; Chronic Disease; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Erythrocytes; Humans; Ibuprofen; Mice; Osteomyelitis; Polyesters; Staphylococcus aureus | 2019 |
In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells.
Topics: Anti-Bacterial Agents; Cell Line; Cell Survival; Chitosan; Ciprofloxacin; Drug Liberation; Epithelial Cells; Escherichia coli; Humans; Lung; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Staphylococcus aureus | 2019 |
Multifunctional prosthetic polyester-based hybrid mesh for repairing of abdominal wall hernias and defects.
Topics: Abdominal Wall; Alginates; Animals; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Dogs; Drug Delivery Systems; Female; Hernia, Abdominal; Male; Micelles; Phenytoin; Polyesters; Prostheses and Implants; Surgical Mesh; Wound Healing | 2019 |
Electrospun Chitosan/Poly (Vinyl Alcohol)/Graphene Oxide Nanofibrous Membrane with Ciprofloxacin Antibiotic Drug for Potential WoundDressing Application.
Topics: Anti-Bacterial Agents; Bandages; Biocompatible Materials; Cell Line; Chitosan; Ciprofloxacin; Graphite; Humans; Membranes, Artificial; Nanofibers; Polyvinyl Alcohol; Wound Healing | 2019 |
Chitosan-induced Synergy for Extended Antimicrobial Potency and Enhanced In Vitro Drug Release of Free Base Ciprofloxacin Nanoplexes.
Topics: Anti-Bacterial Agents; Bacteria; Chitosan; Ciprofloxacin; Drug Design; Drug Liberation; Drug Synergism; Escherichia coli; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Solubility; Staphylococcus aureus | 2020 |
Sustained release of antimicrobials from double-layer nanofiber mats for local treatment of periodontal disease, evaluated using a new micro flow-through apparatus.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Metronidazole; Microbial Sensitivity Tests; Nanofibers; Periodontal Diseases; Polyesters; Polyethylene Glycols; Solubility | 2019 |
Mechanism of formation governs the mechanism of release of antibiotics from calcium phosphate nanopowders and cements in a drug-dependent manner.
Topics: Anti-Bacterial Agents; Calcium Phosphates; Chitosan; Ciprofloxacin; Drug Carriers; Drug Liberation; Gelatin; Hydrogen-Ion Concentration; Hydroxyapatites; Kinetics; Nanostructures; Vancomycin | 2019 |
Chitosan-bacterial cellulose patch of ciprofloxacin for wound dressing: Preparation and characterization studies.
Topics: Anti-Infective Agents; Bandages; Cell Line; Cellulose; Chitosan; Ciprofloxacin; Fibroblasts; Hot Temperature; Humans; Molecular Weight; Permeability; Pseudomonas aeruginosa; Staphylococcus aureus; Thermogravimetry | 2020 |
Fortified hyperbranched PEGylated chitosan-based nano-in-micro composites for treatment of multiple bacterial infections.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bentonite; Chitosan; Ciprofloxacin; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Ibuprofen; Metal Nanoparticles; Microspheres; Nanocomposites; Polyamines; Polyethylene Glycols; Silver; Solubility | 2020 |
Preparation of PLGA-chitosan based nanocarriers for enhancing antibacterial effect of ciprofloxacin in root canal infection.
Topics: Anti-Bacterial Agents; Biofilms; Chitosan; Ciprofloxacin; Dental Pulp Cavity; Dose-Response Relationship, Drug; Drug Carriers; Drug Liberation; Enterococcus faecalis; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Stem Cells | 2020 |
Design of nanostructure chitosan hydrogels for carrying zinc phthalocyanine as a photosensitizer and difloxacin as an antibacterial agent.
Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Chitosan; Ciprofloxacin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hydrogels; Indoles; Isoindoles; Molecular Structure; Organometallic Compounds; Photosensitizing Agents; Rheology; Solubility; Spectroscopy, Fourier Transform Infrared; Temperature; Zinc Compounds | 2020 |
Antibiotic-loaded chitosan-gelatin scaffolds for infected seawater immersion wound healing.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cell Line, Tumor; Chitosan; Ciprofloxacin; Collagen; Cross-Linking Reagents; Cytokines; Gelatin; Iridoids; Male; Mice; Microspheres; Rats; Rats, Sprague-Dawley; Seawater; Transforming Growth Factor beta; Wound Healing | 2020 |
Cerebral effect of optimized Allium sativum oil-loaded chitosan nanorods: GC-MS analysis and in vitro/in vivo evaluation.
Topics: Allyl Compounds; Animals; Brain; Cerebral Cortex; Chitosan; Ciprofloxacin; Drug Delivery Systems; Garlic; Gas Chromatography-Mass Spectrometry; Hippocampus; Male; Nanotubes; Neurotoxicity Syndromes; Oxidative Stress; Particle Size; Plant Extracts; Plant Oils; Rats; Sulfides | 2020 |
Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
Topics: Animals; Anti-Bacterial Agents; Chickens; Chitosan; Chorioallantoic Membrane; Ciprofloxacin; Drug Carriers; Drug Compounding; Liposomes; Ophthalmic Solutions | 2020 |
Preparation of biocompatible chitosan nanoparticles loaded by tetracycline, gentamycin and ciprofloxacin as novel drug delivery system for improvement the antibacterial properties of cellulose based fabrics.
Topics: Cellulose; Chitosan; Ciprofloxacin; Cotton Fiber; Drug Carriers; Drug Delivery Systems; Gentamicins; Microbial Sensitivity Tests; Molecular Structure; Nanoparticles; Spectrum Analysis; Tetracycline; Textiles; Thermogravimetry | 2020 |
Designed sponges based on chitosan and cyclodextrin polymer for a local release of ciprofloxacin in diabetic foot infections.
Topics: Anti-Bacterial Agents; Cellulose; Chitosan; Ciprofloxacin; Cyclodextrins; Diabetes Mellitus; Diabetic Foot; Humans | 2020 |
A Removable Artificial Cell Wall for Withstanding Ciprofloxacin.
Topics: Anti-Bacterial Agents; Aquaculture; Cell Survival; Cell Wall; Chitosan; Ciprofloxacin; Environmental Pollution; Humans; Probiotics | 2020 |
Prevention of bone infection after open fracture using a chitosan with ciprofloxacin implant in animal model.
Topics: Animals; Bony Callus; Chitosan; Ciprofloxacin; Femoral Fractures; Fracture Healing; Fractures, Open; Humans; Infection Control; Infections; Rats; Rats, Wistar; Staphylococcus aureus | 2020 |
Antibiotics removal using a chitosan-based polyelectrolyte in conjunction with ultrafiltration membranes.
Topics: Amoxicillin; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Ecosystem; Humans; Polyelectrolytes; Polymers; Tetracycline; Ultrafiltration; Water Pollutants, Chemical; Water Purification | 2020 |
Optimizing the chitosan-cellulose based drug delivery system for controlling the ciprofloxacin release versus organic/inorganic crosslinker, characterization and kinetic study.
Topics: Cellulose; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Humans; Hydrogels; Nanoparticles | 2020 |
Design and evaluation of ciprofloxacin loaded collagen chitosan oxygenating scaffold for skin tissue engineering.
Topics: Animals; Cell Adhesion; Cell Movement; Cell Survival; Chitosan; Ciprofloxacin; Collagen; Drug Carriers; Drug Delivery Systems; Erythrocytes; Fibroblasts; Humans; Male; Oxygen; Peroxides; Rats; Skin; Spectroscopy, Fourier Transform Infrared; Tetrazolium Salts; Thiazoles; Tissue Engineering; Tissue Scaffolds; Wound Healing; X-Ray Diffraction | 2021 |
Fabrication of ciprofloxacin-loaded chitosan/polyethylene oxide/silica nanofibers for wound dressing application: In vitro and in vivo evaluations.
Topics: Animals; Anti-Bacterial Agents; Bandages; Chitosan; Ciprofloxacin; Mice; Nanofibers; Polyethylene Glycols; Silicon Dioxide | 2021 |
Low molecular weight chitosan-cyanocobalamin nanoparticles for controlled delivery of ciprofloxacin: Preparation and evaluation.
Topics: Chitosan; Ciprofloxacin; Delayed-Action Preparations; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Nanoparticles; Vitamin B 12 | 2021 |
Formulation and characterization of hydroxyapatite-based composite with enhanced compressive strength and controlled antibiotic release.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Compressive Strength; Delayed-Action Preparations; Durapatite; Escherichia coli; Microbial Sensitivity Tests; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Thermogravimetry; X-Ray Diffraction | 2021 |
Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Chitosan; Ciprofloxacin; Drug Carriers; Drug Liberation; Dry Powder Inhalers; Fibrosis; Kinetics; Lipids; Liposomes; Lung; Microbial Sensitivity Tests; Nanostructures; Particle Size; Static Electricity | 2021 |
Chitosan derivatives-based films as pH-sensitive drug delivery systems with enhanced antioxidant and antibacterial properties.
Topics: Anti-Bacterial Agents; Antioxidants; Bacteria; Chitosan; Ciprofloxacin; Cross-Linking Reagents; Drug Carriers; Drug Liberation; Edible Films; Glutaral; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Tensile Strength | 2021 |
Embelin-loaded chitosan gold nanoparticles interact synergistically with ciprofloxacin by inhibiting efflux pumps in multidrug-resistant Pseudomonas aeruginosa and Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Benzoquinones; Chitosan; Ciprofloxacin; Escherichia coli; Escherichia coli Proteins; Gold; Humans; Membrane Transport Proteins; Metal Nanoparticles; Microbial Sensitivity Tests; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Pseudomonas aeruginosa | 2021 |
Dry powder formulation for pulmonary infections: Ciprofloxacin loaded in chitosan sub-micron particles generated by electrospray.
Topics: A549 Cells; Administration, Inhalation; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Humans; Lung Diseases; Microbial Sensitivity Tests; Particle Size; Powders; Pseudomonas aeruginosa; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus | 2021 |
Antimicrobial peptides/ciprofloxacin-loaded O-carboxymethyl chitosan/self-assembling peptides hydrogel dressing with sustained-release effect for enhanced anti-bacterial infection and wound healing.
Topics: Animals; Anti-Bacterial Agents; Bandages; Cell Membrane; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Drug Design; Escherichia coli; Escherichia coli Infections; Hydrogels; Hydrophobic and Hydrophilic Interactions; Male; Melitten; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Peptides; Rheology; Wound Healing | 2022 |
Optimizing the chitosan-PCL based membranes with random/aligned fiber structure for controlled ciprofloxacin delivery and wound healing.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Nanofibers; Polyesters; Wound Healing | 2022 |
Antibacterial activity of chitosan-based nanohybrid membranes against drug-resistant bacterial isolates from burn wound infections.
Topics: Anti-Bacterial Agents; Bentonite; Burns; Chitosan; Ciprofloxacin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Wound Infection | 2022 |
Investigation of the effects of antimicrobial and anti-biofilm peptide IDR1018 and chitosan nanoparticles on ciprofloxacin-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Chitosan; Ciprofloxacin; Escherichia coli Infections; Gentian Violet; Humans; Microbial Sensitivity Tests; Nanoparticles; Uropathogenic Escherichia coli | 2022 |
Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box-Behnken Experimental Design.
Topics: Chitosan; Ciprofloxacin; Drug Carriers; Nanoparticles; Particle Size; Research Design | 2022 |
Screening of Antibacterial Efficacy of Chitosan Encapsulated Probiotics (Lactococcus lactis and Lactobacillus curvattus) against Clinical Bacterial Pathogens.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Buffaloes; Ceftriaxone; Cephalothin; Cephradine; Chitosan; Chloramphenicol; Ciprofloxacin; Erythromycin; Lactobacillus; Lactococcus lactis; Probiotics; Tetracyclines; Tobramycin | 2022 |
Nanosized Combined Antimicrobial Drugs Decreased Emergence of Resistance in
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chitosan; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Meropenem; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Poloxamer; Porins | 2022 |
Simultaneous adsorptive removal of three fluoroquinolones using humic acid modified hydrogel beads.
Topics: Adsorption; Chitosan; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Humic Substances; Hydrogels; Hydrogen-Ion Concentration; Kinetics; Norfloxacin; Water; Water Pollutants, Chemical | 2023 |
Preparation of pectin-chitosan hydrogels based on bioadhesive-design micelle to prompt bacterial infection wound healing.
Topics: Anti-Bacterial Agents; Bacterial Infections; Chitosan; Ciprofloxacin; Humans; Hydrogels; Micelles; Pectins; Water; Wound Healing | 2023 |
Chitosan-Based Ciprofloxacin Extended Release Systems: Combined Synthetic and Pharmacological (In Vitro and In Vivo) Studies.
Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Chitosan; Ciprofloxacin; Drug Liberation; Nanoparticles; Rats | 2022 |
Preparation of mucoadhesive methacrylated chitosan nanoparticles for delivery of ciprofloxacin.
Topics: Animals; Chitosan; Ciprofloxacin; Drug Delivery Systems; Mucous Membrane; Nanoparticles; Sheep | 2023 |
Structural regulatory mechanism of phosphotungstate acid decorated graphene oxide quantum dots-chitosan aerogel and its application in ciprofloxacin degradation.
Topics: Adsorption; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Quantum Dots; Water Pollutants, Chemical | 2023 |
Wound Dressing Scaffold with High Anti-biofilm Performance Based on Ciprofloxacin-Loaded Chitosan-Hydrolyzed Starch Nanocomposite: In Vitro and In Vivo Study.
Topics: Anti-Bacterial Agents; Bandages; Chitosan; Ciprofloxacin; Humans; Nanocomposites; Starch | 2023 |
In vitro investigation of wound healing performance of PVA/chitosan/silk electrospun mat loaded with deferoxamine and ciprofloxacin.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Deferoxamine; Humans; Nanofibers; Polyvinyl Alcohol; Silk; Wound Healing | 2023 |
Photocatalytic degradation of fluoroquinolone antibiotics using chitosan biopolymer functionalized copper oxide nanoparticles prepared by facile sonochemical method.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Copper; Fluoroquinolones; Nanoparticles; Norfloxacin; Oxides | 2023 |
Zinc ions and ciprofloxacin-encapsulated chitosan/poly(ɛ-caprolactone) composite nanofibers promote wound healing via enhanced antibacterial and immunomodulatory.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Ions; Nanofibers; Polyesters; Staphylococcus aureus; Wound Healing; Zinc | 2023 |
Ultra-sensitive detection and scavenging of arsenic ions and ciprofloxacin using 3D multipurpose hemicellulose based aerogel: Adsorption mechanism and RSM optimization.
Topics: Adsorption; Arsenic; Chitosan; Ciprofloxacin; Ions; Kinetics; Water Pollutants, Chemical | 2023 |
Synthesis and Characterization of Antibacterial Chitosan Films with Ciprofloxacin in Acidic Conditions.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared | 2023 |
3-Diethylaminopropyl isothiocyanate modified glycol chitosan for constructing mild-acid sensitive electrospinning antibacterial nanofiber membrane.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Hemostatics; Isothiocyanates; Nanofibers | 2024 |